SCO­TUS de­clines to re­view for­mer In­sys founder John Kapoor's con­vic­tion

3 years ago
Pharma
Law

In­di­ana man­u­fac­tur­er to con­struct fa­cil­i­ty for ra­di­oli­gand pro­duc­tion

3 years ago
R&D
Manufacturing

SPAC merg­er called off as com­pa­ny con­nect­ed to ex-Pur­due CEO de­cides to re­main pri­vate

3 years ago
Financing

With pan-RAF drug from Take­da, Day One un­veils its first pe­di­atric brain can­cer da­ta. And the mar­ket loves it

3 years ago
R&D

No­var­tis may still be grap­pling with Kym­ri­ah sales, but his­toric CAR-T promise still shines through 5-year da­ta

3 years ago
R&D
Pharma

Ho­mol­o­gy cleared to re­sume gene ther­a­py tri­al for rare meta­bol­ic dis­ease af­ter FDA lifts hold

3 years ago
R&D
Cell/Gene Tx

FDA of­fers sup­port for Pfiz­er, Mod­er­na Covid-19 vac­cines for the youngest chil­dren ahead of ad­comm

3 years ago
FDA+
Coronavirus

Look­ing to ex­pand nasal spray in­di­ca­tion, Opti­nose se­cures sec­ond PhI­II win

3 years ago
R&D

Zymeworks adds a clas­sic poi­son pill de­fense to the ar­mory as the biotech's board bat­tles hos­tile takeover

3 years ago
Financing
Deals

Once promis­ing an al­ter­na­tive shot, Val­neva's Covid-19 sup­ply deal with Eu­rope on verge of col­lapse

3 years ago
Pharma
Coronavirus

Amy­lyx picks up ALS drug ap­proval in Cana­da af­ter FDA asks for more time to re­view the da­ta

3 years ago
R&D
FDA+

Sanofi, GSK keep the ball rolling with da­ta on sec­ond-gen Covid vac­cine can­di­date

3 years ago
R&D
Coronavirus

A biotech up­start just scored $103M from Pfiz­er et al to fu­el its pur­suit of a new (to you) I/O path­way

3 years ago
Financing

Pre­view­ing bio­phar­ma trends ahead of #BIO22; Look­ing back at #AS­CO22; Smooth flight for blue­bird?; and more

3 years ago
Weekly

On blue­bird's heels, CRISPR Ther­a­peu­tics and Ver­tex take the air with in­ter­im CRISPR blood cell ther­a­py da­ta

3 years ago
R&D

Blue­bird goes 2-for-2 on gene ther­a­pies at FDA ad­comm with thumbs up for beti-cel

3 years ago
Cell/Gene Tx
FDA+

UK’s NICE grants ac­cess to Amar­in's cho­les­terol drug amid US staff cuts

3 years ago
Pharma

Genen­tech cam­paign aims to in­crease cys­tic fi­bro­sis aware­ness among Lati­no com­mu­ni­ty and health­care providers

3 years ago
Pharma
Marketing

Re­genxbio opens gene ther­a­py man­u­fac­tur­ing fa­cil­i­ty at its Mary­land HQ

3 years ago
Pharma
Cell/Gene Tx

Bavar­i­an Nordic ex­pands mon­key­pox vac­cine deal with US and up­dates '22 sales fig­ures — again

3 years ago
Pharma

Sanofi's Ko­re­an union threat­ens a strike over pay as Big Phar­mas stare down glob­al de­mands

3 years ago
People
Pharma

CSL Behring teams with fa­mous pho­tog­ra­ph­er to fo­cus on he­mo­phil­ia for art ex­hib­it and on­line gallery cam­paign

3 years ago
R&D

Bio­gen yanks its Aduhelm ap­pli­ca­tion in Cana­da, days af­ter cel­e­brat­ing the drug's 1-year an­niver­sary in the US

3 years ago
Pharma

Ahead of ac­cel­er­at­ed ap­proval with­draw­al hear­ing, Co­vis asks FDA to omit study po­ten­tial­ly link­ing Mak­e­na and can­cer

3 years ago
Pharma
FDA+
First page Previous page 514515516517518519520 Next page Last page
A service from the Financial Times